Global Alpha Blockers Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Feb 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Alpha Blockers Market, By Type (Nonselective Alpha-Blockers, Selective Alpha-1 Blockers, Selective Alpha-2 Blockers), Application (Hypertension, Raynaud’s Disease, Erectile Dysfunction, Others), End-Users (Hospitals, Clinics, Home Healthcare, Other), Distribution Channel (Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Alpha Blockers Market Market Analysis and Insights: Global Alpha Blockers Market

Alpha blockers market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 5.50% in the above-mentioned research forecast period. The rising geriatric population and increase in number of patients suffering from blood pressure.

The rising obese population and disease associated with it and increasing product launch also boost up the market growth. Moreover, increasing research and development and rising healthcare expenditure act as opportunity for the market growth. But, side effects associated with alpha blockers, strict regulations and existence of alternative therapies may hamper the global alpha blockers market.

The alpha blockers are the drugs used for treatment of high blood pressure either alone or in combination with other drugs type. Moreover alpha blockers are also used for treatment of prostate problems. Alpha blockers lower down the blood pressure by maintaining the appropriate level of norepinephrine which tightens the muscle in the walls of blood vessels that makes arteries and veins open and relaxed that in turn improves the blood flow and lowers down he blood pressure. As alpha blockers can also relax other types of body’s muscles it is used for improvement of urine flow in men having prostate problems. Alpha blockers are of two types that are short acting medications and long acting medications. The most common alpha blockers used for treatment of blood pressure includes doxazosin, terazosin, and prazosin among several others.

As per the WHO publication worldwide approximately 1.13 billion people suffers from hypertension. Moreover this has been suggested that by 2025 the prevalence of hypertension increase to 29% from 26% in 2019. The increasing prevalence of hypertension poses the tremendous public health concern, which demands the effective therapies and drugs and hence expected to provide market with the lucrative growth.

This alpha blockers market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Alpha Blockers Market Scope and Market Size

Alpha blockers market is segmented on the basis of type, application, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the alpha blockers type market is segmented into nonselective alpha-blockers, selective alpha-1 blockers and selective alpha-2 blockers. Nonselective alpha-blockers is further sub-segmented into phenoxybenzamine and phentolamine. Selective alpha-1 blockers is further sub-segmented into alfuzosin, doxazosin, terazosin, tamsulosin, and prazosin. Selective alpha-2 blockers is sub-segmented into yohimbine and idazoxan.
  • On the basis of application, the alpha blockers type market is segmented into hypertension, Raynaud’s disease, erectile dysfunction and others.
  • On the basis of end-users, the alpha blockers market is segmented into hospitals, clinics, home healthcare, other.
  • On the basis of distribution channel, the alpha blockers market has also been segmented into retail pharmacy, online pharmacy, others. 

Alpha Blockers Market Country Level Analysis

Alpha blockers market is analysed and market size information is provided by country, treatment type, end-users and distribution channel as referenced above.

The countries covered in the alpha blockers market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to rising geriatric population, as per the publication of NCBI the population aged 65 years or more than that will increase to 20.4% in 2050 from 13.3% in 2010 and increasing prevalence of obesity. Europe accounts the second largest market share due to increasing prevalence of blood pressure and other associated urinary tract symptoms in men. Asia-Pacific is expected to account for the largest market share over coming years for the alpha blockers market due to increasing demand of effective therapies and growing awareness for prostate cancer and other urological disease.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Alpha blockers market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Alpha blockers Market Share Analysis

Alpha blockers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to alpha blockers market.

The major players covered in the alpha blockers market are Astra Zeneca, Bayer, Bristol-Myers Squibb, Eli Lily & Company, GlaxoSmith Kline plc, Johnson & Johnson Services, Inc., Celon Laboratories Ltd., Sun Pharmaceutical Industries Ltd., WOCKHARDT, Almelo, Hetero, Pfizer, Dr. Reddy’s Laboratories Ltd, Cipla, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Abbott Laboratories, Sanofi, Aspire Group, Credo Life, Hovione, Zydus Cadila, Teva Pharmaceutical Industries Ltd. among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Alpha blockers Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions